NAP1L1 and hepatocellular carcinoma: Upregulated NAP1L1 increases the expression of the cell cycle protein cyclin D1 (CCND1) by recruiting heparin-binding growth factor (HDGF) and interacting with c-Jun, thereby enhancing the proliferation of HCC cells and promoting tumour progression [13].